{ "items": [ "\n\n
\n \n 20 February 2024\n \n
\n\n \n\n \n\n \n \n \n \n General\n \n \n \n \n Research\n \n \n\n \n\n\n
\n \n\n \n \n \nGout is associated with an increased risk of a broad range of cardiovascular diseases, according to new research which looked at the health records of more than 860,000 people.
\n \n\n\n \n 19 February 2024\n \n
\n\n \n\n \n\n \n \n \n \n General\n \n \n \n \n Research\n \n \n\n \n\n\n
\n \n\n \n \n \nResearchers in Nuffield Departments of Orthopaedics, Rheumatology and Musculoskeletal Sciences (NDORMS) have identified how cells work to resolve frozen shoulder, opening up potential new targets for treatment and reducing the need for surgery.
\n \n\n\n \n 16 February 2024\n \n
\n\n \n\n \n\n \n \n \n \n General\n \n \n \n \n Innovation\n \n \n \n \n Research\n \n \n\n \n\n\n
\n \n\n \n \n \nThis year, around 100,000 people in the UK will have a stroke. AI algorithms developed by a University of Oxford spinout company are ensuring that more stroke patients will receive better care and outcomes.
\n \n\n\n \n 9 February 2024\n \n
\n\n \n\n \n\n \n \n \n \n General\n \n \n \n \n Research\n \n \n\n \n\n\n
\n \n\n \n \n \nNew research from the University of Oxford has revealed that an online program that empowers parents to apply Cognitive Behavioural Therapy (CBT) principles in their child\u2019s day to day lives is just as effective as traditional talking therapies for child anxiety problems, while substantially reducing the amount of therapist time required and making support more accessible for many families. The approach provides parents online tools and some therapist guidance to help children overcome problems with anxiety.
\n \n\n\n \n 5 February 2024\n \n
\n\n \n\n \n\n \n \n \n \n General\n \n \n \n \n Research\n \n \n\n \n\n\n
\n \n\n \n \n \nA team at Nuffield Department of Orthopaedic Rheumatology and Musculoskeletal Sciences (NDORMS) has developed a new approach to significantly improve the accuracy of Ribonucleic acid (RNA) sequencing. They pinpoint the primary source of inaccurate quantification in both short and long-read RNA sequencing, and have introduced the concept of \u201cmajority vote\u201d error correction leading to a substantial improvement in RNA molecular counting.
\n \n\n\n \n 4 February 2024\n \n
\n\n \n\n \n\n \n \n \n \n General\n \n \n \n \n Research\n \n \n\n \n\n\n
\n \n\n \n \n \nThis World Cancer Day, we heard from four Group Leaders at the MRC Weatherall Institute of Molecular Medicine about their work and how their groups are helping in the fight against cancer.
\n \n\n\n \n 1 February 2024\n \n
\n\n \n\n \n\n \n \n \n \n Clinical Trials\n \n \n \n \n General\n \n \n \n \n Research\n \n \n\n \n\n\n
\n \n\n \n \n \nInvestigators immunised over 4800 young children in a trial in Burkina Faso, Kenya, Mali and Tanzania and found on average 78% efficacy in the 5\u201317-month age group over the first year\r\nTo date 25 million doses manufactured and ready for roll-out by The Serum Institute of India (SII) in the next three to four months
\n \n\n\n \n 30 January 2024\n \n
\n\n \n\n \n\n \n \n \n \n General\n \n \n \n \n Research\n \n \n\n \n\n\n
\n \n\n \n \n \nAround 1.6% of women and girls have symptomatic Premenstrual Dysphoric Disorder (PMDD), according to a new review of global studies published in the Journal of Affective Disorders.
\n \n\n\n \n 26 January 2024\n \n
\n\n \n\n \n\n \n \n \n \n General\n \n \n \n \n Research\n \n \n\n \n\n\n
\n \n\n \n \n \nSurgical robotics are amongst the most complex devices entering healthcare, but how should we evaluate them? Published in Nature Medicine, the Idea, Development, Exploration, Assessment and Long-term monitoring (IDEAL) Robotics Colloquium outlines the latest guidance to aid researchers evaluating surgical robots.
\n \n\n\n \n 25 January 2024\n \n
\n\n \n\n \n\n \n \n \n \n General\n \n \n \n \n Research\n \n \n\n \n\n\n
\n \n\n \n \n \nResearchers in Oxford have developed a new, easy-to-use technique for hospitals to contribute to the development of artificial intelligence (AI) models, without patient data leaving the hospital\u2019s premises.
\n \n\n\n \n 25 January 2024\n \n
\n\n \n\n \n\n \n \n \n \n General\n \n \n \n \n Research\n \n \n\n \n\n\n
\n \n\n \n \n \nWomen who are diagnosed with ductal carcinoma in situ (DCIS) outside the National Health Service breast screening programme are around four times as likely to develop invasive breast cancer and to die from breast cancer than women in the general population, finds a University of Oxford study published by the British Medical Journal (BMJ)
\n \n\n\n \n 24 January 2024\n \n
\n\n \n\n \n\n \n \n \n \n General\n \n \n \n \n Research\n \n \n\n \n\n\n
\n \n\n \n \n \nPublished in The Public Library of Science (PLOS), the new guideline will help the scientific community to write complete and transparent research reports involving consensus methods.
\n \n\n\n \n 22 January 2024\n \n
\n\n \n\n \n\n \n \n \n \n General\n \n \n \n \n Research\n \n \n\n \n\n\n
\n \n\n \n \n \nMedical student, Anuraag Vazirani, and fellow colleagues from St Cross College, recently published a paper in the journal Scientific Reports, in which they introduce Innovation Enhancing Techniques (IETs) to address challenges in healthcare and biomedicine, offering a versatile framework for creative solutions. Their study aims to give entrepreneurs, innovators, and researchers a toolkit to create innovative solutions to problems they are trying to solve. By adapting a technique called 'BrainSwarming', which enables a problem-solver to overcome psychological obstacles to thinking up new solutions to a problem, they can effectively generate innovative solutions - an alternative to traditional 'brainstorming'.
\n \n\n\n \n 22 January 2024\n \n
\n\n \n\n \n\n \n \n \n \n General\n \n \n \n \n Research\n \n \n\n \n\n\n
\n \n\n \n \n \nResearchers from the Medical Research Council Brain Network Dynamics Unit at the University of Oxford and the Nuffield Department of Clinical Neurosciences have identified a novel mechanism by which the brain produces powerful lasting memories that drive ill-advised actions.
\n \n\n\n \n 19 January 2024\n \n
\n\n \n\n \n\n \n \n \n \n General\n \n \n \n \n Innovation\n \n \n \n \n Research\n \n \n\n \n\n\n
\n \n\n \n \n \nThe DETECT study, led by Nuffield Department of Women's and Reproductive Health Professors Christian Becker and Krina Zondervan explores the potential of visualizing endometriosis, including hard-to-detect superficial peritoneal disease, using Serac's innovative imaging agent.
\n \n\n\n \n 18 January 2024\n \n
\n\n \n\n \n\n \n \n \n \n General\n \n \n \n \n Research\n \n \n\n \n\n\n
\n \n\n \n \n \nA recent study led by the Centre for Human Genetics at the Nuffield Department of Medicine has revealed that areas of the human genome that are routinely overlooked in clinical tests may be the cause of some rare diseases.
\n \n\n\n \n 17 January 2024\n \n
\n\n \n\n \n\n \n \n \n \n General\n \n \n \n \n Research\n \n \n\n \n\n\n
\n \n\n \n \n \nThe Oxford Experimental Medicine Clinical Research Facility (EMCRF) at Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences (NDORMS) has received its first volunteers as part of the LEGACY03 trial to improve vaccine design for different age groups.
\n \n\n\n \n 16 January 2024\n \n
\n\n \n\n \n\n \n \n \n \n General\n \n \n \n \n Research\n \n \n\n \n\n\n
\n \n\n \n \n \nThe Jenner Institute is conducting a new study, using BCG, the current licensed vaccine against tuberculosis. In this study, they will give BCG a second time to people who have already had BCG once before, and will compare whether giving it by inhalation is better at protecting people against tuberculosis than giving it into the skin
\n \n\n\n \n 15 January 2024\n \n
\n\n \n\n \n\n \n \n \n \n General\n \n \n \n \n Research\n \n \n\n \n\n\n
\n \n\n \n \n \nResearch led by scientists at the Universities of Oxford, Cambridge, Copenhagen, Bristol and California (Berkeley) reveals the evolutionary origins of multiple sclerosis (MS). This new insight into the genetic architecture of this disease changes scientists\u2019 view of its causes and has implications for its treatment, as well as paving the way for further investigations into other diseases.
\n \n\n\n \n 12 January 2024\n \n
\n\n \n\n \n\n \n \n \n \n General\n \n \n \n \n Research\n \n \n\n \n\n\n
\n \n\n \n \n \nFirst clinical trial participants received doses of the ChAdOx1 NipahB vaccine over the last week at University of Oxford. UK trial is first step to developing a vaccine against Nipah virus \u2013 a devastating disease mostly found in South-East Asia \u2013 that can be fatal in up to 75% of cases. The milestone clinical trial comes as the global health community marks the 25th anniversary of the first Nipah virus outbreaks. There are still no approved vaccines or treatments for the disease.
\n \n\n